APA (7th ed.) Citation

J, C., D, L., RF, S., & JL, M. (2004). Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: Novel insights into the role of RAS and dyslipidemia in atherogenesis. Journal of cardiovascular pharmacology, 44(4), 446. https://doi.org/10.1097/01.fjc.0000140205.74180.3c

Chicago Style (17th ed.) Citation

J, Chen, Li D, Schaefer RF, and Mehta JL. "Inhibitory Effect of Candesartan and Rosuvastatin on CD40 and MMPs Expression in Apo-E Knockout Mice: Novel Insights into the Role of RAS and Dyslipidemia in Atherogenesis." Journal of Cardiovascular Pharmacology 44, no. 4 (2004): 446. https://doi.org/10.1097/01.fjc.0000140205.74180.3c.

MLA (9th ed.) Citation

J, Chen, et al. "Inhibitory Effect of Candesartan and Rosuvastatin on CD40 and MMPs Expression in Apo-E Knockout Mice: Novel Insights into the Role of RAS and Dyslipidemia in Atherogenesis." Journal of Cardiovascular Pharmacology, vol. 44, no. 4, 2004, p. 446, https://doi.org/10.1097/01.fjc.0000140205.74180.3c.